Developing new drugs to treat and prevent malaria.
BLR&D Research Career Scientist Renewal Application
['FUNDING_OTHER'] · PORTLAND VA MEDICAL CENTER · NIH-11052837
This study is working on developing new oral medications to treat and prevent malaria, aiming to create effective options for people battling this serious disease, especially in light of growing drug resistance.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PORTLAND VA MEDICAL CENTER (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-11052837 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and optimizing new antiparasitic drugs specifically aimed at treating and preventing malaria, a serious tropical disease. The laboratory employs advanced drug design and chemical synthesis techniques to develop five novel classes of antimalarial compounds that have shown effectiveness in laboratory models. These compounds are designed to be taken orally and have the potential to be curative, addressing the challenge of drug resistance in malaria treatment. The research aims to translate these findings into viable treatments for patients suffering from malaria.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of malaria infection, particularly those living in or traveling to endemic regions.
Not a fit: Patients who do not live in malaria-endemic areas or who are not at risk of malaria infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and accessible treatments for malaria, potentially saving lives.
How similar studies have performed: Previous research has shown success in developing new antimalarial drugs using similar innovative approaches, indicating a promising avenue for future breakthroughs.
Where this research is happening
PORTLAND, UNITED STATES
- PORTLAND VA MEDICAL CENTER — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RISCOE, MICHAEL KEVIN — PORTLAND VA MEDICAL CENTER
- Study coordinator: RISCOE, MICHAEL KEVIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus